Literature DB >> 23238172

Overview of the therapeutic potential of piplartine (piperlongumine).

Daniel P Bezerra1, Claudia Pessoa2, Manoel O de Moraes2, Nicolau Saker-Neto3, Edilberto R Silveira3, Leticia V Costa-Lotufo2.   

Abstract

Piplartine (piperlongumine, 5,6-dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone) is a biologically active alkaloid/amide from peppers, as from long pepper (Piper longum L. - Piperaceae). Long pepper is one of the most widely used in Ayurvedic medicine, which is used to treat many diseases, including tumors. The purpose of the current paper is to address to the chemical structure establishment and to systematically survey the published articles and highlight recent advances in the knowledge of the therapeutic potential of piplartine, establishing new goals for future research. The reported pharmacological activities of piplartine include cytotoxic, genotoxic, antitumor, antiangiogenic, antimetastatic, antiplatelet aggregation, antinociceptive, anxiolytic, antidepressant, anti-atherosclerotic, antidiabetic, antibacterial, antifungal, leishmanicidal, trypanocidal, and schistosomicidal activities. Among the multiple pharmacological effects of piplartine, its anticancer property is the most promising. Therefore, the preclinical anticancer potential of piplartine has been extensively investigated, which recently resulted in one patent. This compound is selectively cytotoxic against cancer cells by induction of oxidative stress, induces genotoxicity, as an alternative strategy to killing tumor cells, has excellent oral bioavailability in mice, inhibits tumor growth in mice, and presents only weak systemic toxicity. In summary, we conclude that piplartine is effective for use in cancer therapy and its safety using chronic toxicological studies should be addressed to support the viability of clinical trials.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238172     DOI: 10.1016/j.ejps.2012.12.003

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  77 in total

1.  Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.

Authors:  Xingui Liu; Yingying Wang; Xuan Zhang; Zhengya Gao; Suping Zhang; Peizhong Shi; Xin Zhang; Lin Song; Howard Hendrickson; Daohong Zhou; Guangrong Zheng
Journal:  Bioorg Med Chem       Date:  2018-06-18       Impact factor: 3.641

2.  JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells.

Authors:  Wen Li; Chuangyu Wen; Haiyan Bai; Xiaoyan Wang; Xiaoli Zhang; Lanlan Huang; Xiangling Yang; Aikichi Iwamoto; Huanliang Liu
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

3.  Antileishmanial activity evaluation of a natural amide and its synthetic analogs against Leishmania (V.) braziliensis: an integrated approach in vitro and in silico.

Authors:  Minelly A da Silva; Harold H Fokoue; Saara N Fialho; Ana Paula de A Dos Santos; Norton R D L P Rossi; Aurileya de J Gouveia; Amália S Ferreira; Guilherme M Passarini; Ana F G Garay; Jorge J Alfonso; Andreimar M Soares; Fernando B Zanchi; Massuo J Kato; Carolina B G Teles; Christian C Kuehn
Journal:  Parasitol Res       Date:  2021-05-08       Impact factor: 2.289

4.  Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.

Authors:  Nikee Awasthee; Anusmita Shekher; Vipin Rai; Sumit S Verma; Shruti Mishra; Anupam Dhasmana; Subash C Gupta
Journal:  Apoptosis       Date:  2022-02-04       Impact factor: 4.677

5.  Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.

Authors:  Yin-Ju Chen; Chia-Chun Kuo; Lai-Lei Ting; Long-Sheng Lu; Ya-Ching Lu; Ann-Joy Cheng; Yun-Tien Lin; Chien-Ho Chen; Jo-Ting Tsai; Jeng-Fong Chiou
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

6.  Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Siqi Xu; Youjun Xiao; Shan Zeng; Yaoyao Zou; Qian Qiu; Mingcheng Huang; Zhongping Zhan; Liuqin Liang; Xiuyan Yang; Hanshi Xu
Journal:  Inflamm Res       Date:  2017-11-08       Impact factor: 4.575

7.  Antischistosomal Activity of Oxindolimine-Metal Complexes.

Authors:  Josué de Moraes; Bruno S Dario; Ricardo A A Couto; Pedro L S Pinto; Ana M da Costa Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

8.  Multidrug resistance-selective antiproliferative activity of Piper amide alkaloids and synthetic analogues.

Authors:  Yue-Hu Wang; Masuo Goto; Li-Ting Wang; Kan-Yen Hsieh; Susan L Morris-Natschke; Gui-Hua Tang; Chun-Lin Long; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2014-09-06       Impact factor: 2.823

9.  Synthesis of piperlogs and analysis of their effects on cells.

Authors:  Zarko V Boskovic; Mahmud M Hussain; Drew J Adams; Mingji Dai; Stuart L Schreiber
Journal:  Tetrahedron       Date:  2013-09-09       Impact factor: 2.457

Review 10.  Medulloblastoma drugs in development: Current leads, trials and drawbacks.

Authors:  Jiachen Wen; M Kyle Hadden
Journal:  Eur J Med Chem       Date:  2021-02-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.